CL2017002255A1 - Procesos para preparar fluorocetólidos. - Google Patents

Procesos para preparar fluorocetólidos.

Info

Publication number
CL2017002255A1
CL2017002255A1 CL2017002255A CL2017002255A CL2017002255A1 CL 2017002255 A1 CL2017002255 A1 CL 2017002255A1 CL 2017002255 A CL2017002255 A CL 2017002255A CL 2017002255 A CL2017002255 A CL 2017002255A CL 2017002255 A1 CL2017002255 A1 CL 2017002255A1
Authority
CL
Chile
Prior art keywords
processes
fluorocetolides
prepare
fluorocetolide
intermediates
Prior art date
Application number
CL2017002255A
Other languages
English (en)
Inventor
David Eugene Pereira
Stephen E Schneider
Keshav Deo
Original Assignee
Cempra Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cempra Pharmaceuticals Inc filed Critical Cempra Pharmaceuticals Inc
Publication of CL2017002255A1 publication Critical patent/CL2017002255A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Abstract

<p>En la presente, se describen procesos e intermediarios para preparar compuestos de fluorocetólido.</p>
CL2017002255A 2015-03-06 2017-09-06 Procesos para preparar fluorocetólidos. CL2017002255A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562129305P 2015-03-06 2015-03-06

Publications (1)

Publication Number Publication Date
CL2017002255A1 true CL2017002255A1 (es) 2018-05-11

Family

ID=56880477

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017002255A CL2017002255A1 (es) 2015-03-06 2017-09-06 Procesos para preparar fluorocetólidos.

Country Status (19)

Country Link
US (2) US20180044365A1 (es)
EP (1) EP3265100A4 (es)
JP (1) JP6773672B2 (es)
KR (1) KR20170133377A (es)
CN (1) CN107405355A (es)
AU (1) AU2016230027A1 (es)
BR (1) BR112017019176A2 (es)
CA (1) CA2978731A1 (es)
CL (1) CL2017002255A1 (es)
CO (1) CO2017010143A2 (es)
HK (1) HK1247097A1 (es)
IL (1) IL254306A0 (es)
MX (2) MX2017011454A (es)
PE (1) PE20180219A1 (es)
RU (1) RU2017131253A (es)
SG (2) SG11201707215XA (es)
TW (1) TW201638102A (es)
WO (1) WO2016144833A1 (es)
ZA (1) ZA201706505B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
WO2010048601A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3668282A (en) * 1970-05-08 1972-06-06 Stauffer Chemical Co Stabilized mixture employing n-(beta-0,0-dialkyldithiophosphoryl) aryl sulfonamides
WO2004080391A2 (en) * 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US7595300B2 (en) * 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
CN101917850B (zh) * 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
US8283012B2 (en) * 2008-07-24 2012-10-09 Ideo Llc Printable pre-sewn stuffed toy composite sheets
JP5718488B2 (ja) * 2011-03-01 2015-05-13 ウォックハート リミテッド ケトライド中間体の調製方法
US9861616B2 (en) * 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
KR20160020403A (ko) * 2013-03-15 2016-02-23 셈프라 파마슈티컬스, 인크. 매크로라이드 항세균제들을 제조하기 위한 수렴 프로세스들
CA3130061A1 (en) * 2013-04-04 2014-10-09 President And Fellows Of Harvard College Macrolides and methods of their preparation and use

Also Published As

Publication number Publication date
PE20180219A1 (es) 2018-01-31
US20210070797A1 (en) 2021-03-11
CA2978731A1 (en) 2016-09-15
JP6773672B2 (ja) 2020-10-21
AU2016230027A1 (en) 2017-09-28
WO2016144833A1 (en) 2016-09-15
BR112017019176A2 (pt) 2018-04-24
SG10201908248PA (en) 2019-10-30
MX2017011454A (es) 2018-01-23
SG11201707215XA (en) 2017-10-30
MX2020007742A (es) 2020-09-25
EP3265100A4 (en) 2019-01-09
HK1247097A1 (zh) 2018-09-21
IL254306A0 (en) 2017-11-30
JP2018508537A (ja) 2018-03-29
KR20170133377A (ko) 2017-12-05
CO2017010143A2 (es) 2018-02-28
EP3265100A1 (en) 2018-01-10
US20180044365A1 (en) 2018-02-15
TW201638102A (zh) 2016-11-01
RU2017131253A (ru) 2019-04-08
CN107405355A (zh) 2017-11-28
ZA201706505B (en) 2021-04-28

Similar Documents

Publication Publication Date Title
CL2016002455A1 (es) Anticuerpos multiespecíficos.
CU20180001A7 (es) Derivados de oxopiridina sustituidos y procesos para su preparación
CL2016001871A1 (es) Anticuerpos humanos para pd-1
EA201891211A1 (ru) Ингибиторы cxcr2
BR112017003414A2 (pt) composições compreendendo caseína e métodos para produzir as mesmas
EA201692219A1 (ru) Способы получения противовирусных соединений
CL2017001185S1 (es) Automovil
UY34824A (es) Nucleósidos de espirooxetano de uracilo
TR201906366T4 (tr) Polisiklik-karbamoilpiridon bileşiklerinin sentezi.
AR095075A1 (es) Acoplamiento electroquímico de anilinas
CL2017002255A1 (es) Procesos para preparar fluorocetólidos.
IT201600117287A1 (it) Metodo di trasfezione transiente per produzione retrovirale.
UY36737A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
BR112016029510A2 (pt) métodos para a preparação de um composto, e, composto intermediário.
BR112017001391A2 (pt) componentes para o fusionamento de corpos vertebrais
CL2016001488A1 (es) Quinazolin-thf-aminas como inhibidores de pde1
BR112017002139A2 (pt) ?método para preparar um composto?
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
CL2016002256A1 (es) Un proceso mejorado para la preparación de exametazima
MX351329B (es) Proceso para elaborar derivados de magnolol.
CL2017002653A1 (es) Procedimiento y reactor para fijar arsénico.
CL2016002925A1 (es) Procedimiento mejorado para preparar ácidos crotónicos sustituidos
ITUB20159583A1 (it) Autocombustore di biomassa.
ES2722574R1 (es) Proceso para la preparación de 9beta,10alfa-progesterona (retroprogesterona)